Pathological Role of Anti-CD4 Antibodies in HIV-Infected Immunologic Nonresponders Receiving Virus-Suppressive Antiretroviral Therapy

The Journal of Infectious Diseases
Zhenwu LuoWei Jiang

Abstract

Increased mortality and morbidity occur among human immunodeficiency virus (HIV)-infected patients in whom CD4+ T-cell counts do not increase despite viral suppression with antiretroviral therapy (ART). Here we identified an underlying mechanism. Significantly elevated plasma levels of anti-CD4 immunoglobulin G (IgG) were found in HIV-positive immunologic nonresponders (ie, HIV-positive individuals with CD4+ T-cell counts of ≤350 cells/μL), compared with levels in HIV-positive immunologic responders (ie, HIV-positive individuals with CD4+ T-cell counts of ≥500 cells/μL) and healthy controls. Higher plasma level of anti-CD4 IgG correlated with blunted CD4+ T-cell recovery. Furthermore, purified anti-CD4 IgG from HIV-positive immunologic nonresponders induced natural killer (NK) cell-dependent CD4+ T-cell cytolysis and apoptosis through antibody-dependent cell-mediated cytotoxicity (ADCC) in vitro. We also found that anti-CD4 IgG-mediated ADCC exerts greater apoptosis of naive CD4+ T cells relative to memory CD4+ T cells. Consistently, increased frequencies of CD107a+ NK cells and profound decreases of naive CD4+ T cells were observed in immunologic nonresponders as compared to responders and healthy controls ex vivo. These data ...Continue Reading

References

Feb 1, 1992·The Journal of Clinical Investigation·A ShiraiD M Klinman
Jan 1, 1991·Clinical Immunology and Immunopathology·I SekigawaR A Byrn
Jan 1, 1990·Epidemiology·K J Rothman
Dec 31, 1997·AIDS·P S MassabkiL E Andrade
Jun 8, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·G J WiegersJ M Reul
Jul 10, 2003·Autoimmunity Reviews·Gisele Zandman-Goddard, Yehuda Shoenfeld
Apr 25, 2006·The Lancet Infectious Diseases·Manuel BattegayGilbert R Kaufmann
Apr 23, 2008·AIDS·Jason V BakerUNKNOWN Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA)
Aug 30, 2008·Nature Clinical Practice. Rheumatology·Keith Elkon, Paolo Casali
Jan 1, 2009·Médecine sciences : M/S·Jérôme Estaquier, Bruno Hurtrel
Feb 6, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Colleen F KelleySteven G Deeks
Apr 7, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Eugènia NegredoJulià Blanco
Jul 1, 2010·AIDS·Alba DiazUNKNOWN Study Group of Lymphoid Tissue immunopathogenesis in HIV infection
Sep 16, 2011·The Journal of Infectious Diseases·Michael M LedermanBenigno Rodriguez
Sep 3, 2013·Journal of Clinical Immunology·Yongjun JiangHong Shang
Mar 13, 2014·The Journal of Clinical Investigation·Mattia BonsignoriBarton F Haynes
Dec 2, 2015·PLoS Pathogens·Balthasar A HeestersMichael C Carroll

❮ Previous
Next ❯

Citations

Mar 13, 2021·Journal of Neurovirology·Scott BowlerLishomwa C Ndhlovu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.